Robert Schrepfer
2020
In 2020, Robert Schrepfer earned a total compensation of $2.7M as Former Senior Vice President, New Business Development and Specialty Sales at ANI Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
Bonus | $288,792 |
---|---|
Salary | $474,273 |
Stock Awards | $1,877,400 |
Other | $18,498 |
Total | $2,658,963 |
Schrepfer received $1.9M in stock awards, accounting for 71% of the total pay in 2020.
Schrepfer also received $288.8K in bonus, $474.3K in salary and $18.5K in other compensation.
Rankings
In 2020, Robert Schrepfer's compensation ranked 4,317th out of 13,090 executives tracked by ExecPay. In other words, Schrepfer earned more than 67.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,317 out of 13,090 | 67th |
Division Manufacturing | 1,749 out of 5,624 | 69th |
Major group Chemicals And Allied Products | 683 out of 2,257 | 70th |
Industry group Drugs | 584 out of 1,957 | 70th |
Industry Pharmaceutical Preparations | 444 out of 1,462 | 70th |
Source: SEC filing on April 29, 2021.
Schrepfer's colleagues
We found five more compensation records of executives who worked with Robert Schrepfer at ANI Pharmaceuticals in 2020.
2020
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
2020
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
2020
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
2020
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
2020
Arthur Przybyl
ANI Pharmaceuticals